Combined incidence of OHSS in phase 3 trials of corifollitropin alfa for controlled ovarian stimulation

被引：0
|
作者：
Tarlatzis, B. [1 ]
Witjes, H. [2 ]
Mannaerts, B. [3 ]
机构：
[1] Papageorgiou Hosp, Human Reprod Unit, Dept Obstet & Gynecol 1, Thessaloniki, Greece
[2] Schering Plough Res Inst, Global Late Stage Stat, Oss, Netherlands
[3] Schering Plough Res Inst, Global Clin Res Womens Hlth, Oss, Netherlands
来源：
HUMAN REPRODUCTION | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：I242 / I242
页数：1
相关论文
共 50 条
  • [41] Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction
    M. Ludwig
    R. E. Felberbaum
    P. Devroey
    C. Albano
    H. Riethmüller-Winzen
    A. Schüler
    W. Engel
    K. Diedrich
    Archives of Gynecology and Obstetrics, 2000, 264 : 29 - 32
  • [42] Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a GnRH antagonist protocol
    Griesinger, G.
    Rombauts, L.
    Van Kuijk, J.
    Mannaerts, B.
    HUMAN REPRODUCTION, 2012, 27
  • [43] Follicle-stimulating hormone receptor genotype and its influence on the results of ovarian stimulation using corifollitropin alfa
    Hortal Foronda, M.
    Cascales, A.
    Ortiz, J. A.
    Lledo, B.
    Guerrero, J.
    Bernabeu, A.
    Bernabeu, R.
    HUMAN REPRODUCTION, 2022, 37 : I459 - I460
  • [44] Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35-42 years with a body weight ≥50 kg: a randomized controlled trial
    Vuong, N. L.
    Pham, D. T.
    Phung, H. T.
    Giang, H. N.
    Huynh, G. B.
    Nguyen, T. T. L.
    Ho, M. T.
    HUMAN REPRODUCTION OPEN, 2017, 2017 (03)
  • [45] Ovarian stimulation with corifollitropin alfa followed by hp-hMG compared to hp-hMG in patients at risk of poor ovarian response undergoing ICSI: A randomized controlled trial
    Taronger, Roser
    Martinez-Cuenca, Susana
    Ferreros, Inmaculada
    Rubio, Jose M.
    Fernandez-Colom, Pedro J.
    Luisa Martinez-Triguero, M.
    Pellicer, Antonio
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 231 : 192 - 197
  • [46] Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study
    Cruz, Maria
    Alama, Pilar
    Munoz, Manuel
    Collado, Diana
    Blanes, Carlos
    Solbes, Enrique
    Requena, Antonio
    REPRODUCTIVE BIOMEDICINE ONLINE, 2017, 34 (06) : 605 - 610
  • [47] Conventional ovarian stimulation vs. delayed single dose corifollitropin alfa ovarian stimulation in oocyte donors: a prospective randomized study. Tail trial
    Alvarado Franco, Carlos Alberto
    Bernabeu Garcia, Andrea
    Sunol Sala, Jordi
    Guerrero Villena, Jaime
    Albero Amoros, Sonia
    Llacer, Joaquin
    Delgado Navas, Ricardo Antonio
    Ortiz, Jose A.
    Pitas, Anna
    Castillo Farfan, Juan Carlos
    Bernabeu Perez, Rafael
    FRONTIERS IN REPRODUCTIVE HEALTH, 2023, 5
  • [48] ACCEPTABILITY AND RESULTS OF CORIFOLLITROPIN ALFA (FSH-CFT) AND DESOGESTREL (DSG) FOR OVARIAN STIMULATION (COH) IN OOCYTE DONORS (OD)
    Martinez, F.
    Rodriguez-Barredo, D.
    Rodriguez-Purata, J.
    Clua, E.
    Rodriguez, I.
    Coroleu, B.
    FERTILITY AND STERILITY, 2017, 108 (03) : E232 - E232
  • [49] Corifollitropin alfa is safe and efficacious in IVF patients undergoing repeated gonadotropin-releasing hormone antagonist ovarian stimulation cycles
    Rombauts, L.
    Heijnen, E.
    Marintcheva-Petrova, M.
    Elbers, J.
    HUMAN REPRODUCTION, 2010, 25 : I242 - I243
  • [50] Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome
    Bonduelle, Maryse
    Mannaerts, Bernadette
    Leader, Arthur
    Bergh, Christina
    Passier, Dorrie
    Devroey, Paul
    HUMAN REPRODUCTION, 2012, 27 (07) : 2177 - 2185
12345